Anthem (NASDAQ:ANTX) Director Robin Shane Readnour Sells 6,100 Shares

Anthem, Inc. (NASDAQ:ANTX) Director Robin Shane Readnour sold 6,100 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $6.07, for a total value of $37,027.00. Following the transaction, the director owned 562,715 shares of the company’s stock, valued at $3,415,680.05. This trade represents a 1.07% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Robin Shane Readnour also recently made the following trade(s):

• On Tuesday, September 8th, Robin Shane Readnour sold 10,019 shares of Anthem stock. The shares were sold at an average price of $6.02, for a total value of $60,314.38.
• On Monday, August 17th, Robin Shane Readnour sold 35,402 shares of Anthem stock. The shares were sold at an average price of $6.01, for a total value of $212,766.02.

Anthem Price Performance

Anthem stock opened at $5.98 on Wednesday. The firm has a market capitalization of $225.66 million, a P/E ratio of -5.59 and a beta of -0.99. The stock has a fifty day moving average price of $5.33 and a two-hundred day moving average price of $4.41. Anthem, Inc. has a 52-week low of $1.00 and a 52-week high of $7.19.

Anthem (NASDAQ:ANTX) last issued its earnings results on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.

Institutional Investors Weigh In On Anthem

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Seven Fleet Capital Management LP increased its holdings in Anthem by 4.6% in the second quarter. Seven Fleet Capital Management LP now owns 208,946 shares of the company’s stock valued at $1,011,000 after purchasing an additional 9,245 shares during the last quarter. Velan Capital Investment Management LP acquired a new position in shares of Anthem during the 2nd quarter worth about $194,000. Citizens Financial Group Inc. RI acquired a new position in shares of Anthem during the 2nd quarter worth about $1,443,000. Vivo Capital LLC bought a new stake in shares of Anthem in the 1st quarter valued at about $10,785,000. Finally, Bank of America Corp DE raised its position in shares of Anthem by 2.2% in the 1st quarter. Bank of America Corp DE now owns 393,702 shares of the company’s stock valued at $1,346,000 after acquiring an additional 8,390 shares during the period. Institutional investors own 90.47% of the company’s stock.

Wall Street Analyst Weigh In

ANTX has been the subject of several recent analyst reports. Leerink Partners raised shares of Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price objective for the company in a report on Thursday, May 14th. Weiss Ratings restated a “sell (d-)” rating on shares of Anthem in a research report on Monday, July 6th. Wall Street Zen upgraded shares of Anthem from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th. Finally, Guggenheim initiated coverage on shares of Anthem in a research report on Monday, July 20th. They set a “buy” rating and a $9.00 price target for the company. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Anthem currently has a consensus rating of “Hold” and a consensus price target of $9.00.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.